BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Drug Development

  Immunomedics, Inc. Release: Final Therapy and Safety Results From Phase I/II Study of Veltuzumab, a Second-Generation Anti-CD20 Humanized Antibody, Published

  May 19, 2009

   · 

  1 min read
• Hyatt CEO Announces New Twitter Strategy

  May 19, 2009

   · 

  1 min read
• Genetown

  Bruker Daltonics Inc. Expands the Boundaries of Ultra-High Performance Mass Spectrometry with the Introduction of solariX(TM), the Next-Generation FTMS Platform

  May 19, 2009

   · 

  1 min read
• Genetown

  InVivo Therapeutics Corporation CEO Frank Reynolds Nominated as ‘CEO of the Year’

  May 19, 2009

   · 

  1 min read
• ExcellGene First Company To Offer Contract Manufacturing In 250 Liter Orbshake Bioreactor

  May 19, 2009

   · 

  3 min read
• Biotech Beach

  Avid Bioservices, Inc. Executive Explains How to Select the Right CMO to Achieve Biosimilar Success

  May 19, 2009

   · 

  1 min read
• Business

  Celerus Diagnostics Adds International Distribution Expert to Management Team

  May 19, 2009

   · 

  1 min read
• Biotech Beach

  Beckman Coulter, Inc. Prices $500 Million Senior Notes Offering

  May 19, 2009

   · 

  3 min read
• Deals

  Encorium Group, Inc. Provides Update to LOI with Respect to the Sale of its U.S. Business

  May 19, 2009

   · 

  5 min read
• Biotech Beach

  Cytokinetics, Inc. Announces Registered Direct Common Stock Offering of $14.0 Million

  May 19, 2009

   · 

  6 min read